← Back to PDSB

PDS Biotechnology Corporation - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Dec 2025Filed 30/03/2026Sep 2025Filed 30/03/2026Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Dec 2024Filed 30/03/2026Sep 2024Filed 30/03/2026
−$9.8−$7.3−$7.6−$9−$9.4−$8.5−$8−$11
−$0.18−$0.13−$0.19−$0.21−$0.21−$0.29
565547464137

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.